WPI 3155 (Modafinil 200 mg)
Pill imprint WPI 3155 has been identified as Modafinil 200 mg.
Modafinil is used in the treatment of shift work sleep disorder; narcolepsy; obstructive sleep apnea/hypopnea syndrome; adhd; chronic fatigue syndrome (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 200 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
More about modafinil
- Other brands: Provigil
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.